Scarica l'app Stockscreener
291.55
0.18%
-0.52
Dopo l'orario di chiusura:
291.55
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$292.07
Aprire:
$295.52
Volume 24 ore:
1.37M
Relative Volume:
0.77
Capitalizzazione di mercato:
$56.51B
Reddito:
$310.23B
Utile/perdita netta:
$1.69B
Rapporto P/E:
33.82
EPS:
8.62
Flusso di cassa netto:
$3.58B
1 W Prestazione:
-0.63%
1M Prestazione:
-0.20%
6M Prestazione:
+16.60%
1 anno Prestazione:
+26.48%
Intervallo 1D:
$288.20
$296.70
Intervallo di 1 settimana:
$285.98
$296.70
Portata 52W:
$218.65
$309.35
Cencora Inc Stock (COR) Company Profile
Nome
Cencora Inc
Settore
Industria
Telefono
610-727-7000
Indirizzo
1 WEST FIRST AVENUE, CONSHOHOCKEN
Confronta COR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
291.55 | 56.87B | 310.23B | 1.69B | 3.58B | 8.62 |
|
MCK
Mckesson Corporation
|
714.88 | 90.05B | 359.05B | 3.30B | 5.23B | 25.83 |
|
CAH
Cardinal Health Inc
|
155.48 | 36.92B | 222.29B | 1.56B | 2.44B | 6.41 |
|
HSIC
Henry Schein Inc
|
70.57 | 9.21B | 12.50B | 314.00M | 421.00M | 2.44 |
|
YI
111 Inc Adr
|
8.08 | 69.56M | 2.05B | -45.99M | 5.54M | -0.5634 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-09-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Equal Weight |
| 2023-03-31 | Iniziato | Citigroup | Buy |
| 2023-01-31 | Ripresa | Evercore ISI | Outperform |
| 2022-10-11 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-08-22 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-07-11 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-06-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-05-26 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-04-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2021-03-12 | Ripresa | Evercore ISI | In-line |
| 2021-02-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-02-02 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2021-01-06 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-01-06 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | Iniziato | Mizuho | Neutral |
| 2020-08-06 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | Iniziato | Barclays | Underweight |
| 2020-06-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | Ripresa | Credit Suisse | Outperform |
| 2020-04-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-03-17 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-02-11 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-07-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | Iniziato | Guggenheim | Buy |
| 2019-04-10 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-02-11 | Downgrade | JP Morgan | Neutral → Underweight |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-10 | Downgrade | Jefferies | Buy → Hold |
| 2018-10-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | Iniziato | Berenberg | Buy |
| 2018-07-17 | Ripresa | Stifel | Hold |
| 2018-04-09 | Iniziato | MoffettNathanson | Buy |
| 2018-03-12 | Aggiornamento | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | Iniziato | JP Morgan | Neutral |
| 2017-09-22 | Iniziato | William Blair | Outperform |
Mostra tutto
Cencora Inc Borsa (COR) Ultime notizie
Wells Fargo Upgrades Cencora (COR) Stock to Overweight, Lifts PT - Insider Monkey
Cardinal Health stock, Cencora stock upgraded at Wells Fargo - Seeking Alpha
Wells Fargo Upgrades Cencora (COR) - Nasdaq
Wells Fargo upgrades Cencora stock rating, raises price target to $337 - Investing.com
Wells Fargo Upgrades Cencora (COR) with Raised Price Target | COR Stock News - GuruFocus
Cencora (COR) Receives Upgrade as Analysts Set New Price Target - GuruFocus
Wells Fargo Elevates Cencora (COR) to Overweight with Raised Price Target | COR Stock News - GuruFocus
Insider Sell Alert: Lazarus Krikorian Sells 3,000 Shares of Cencora Inc (COR) - GuruFocus
Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Cencora, Inc. Declares Quarterly Cash Dividend, Payable on June 2, 2025 - marketscreener.com
Here's Why You Should Add Cencora Stock to Your Portfolio Now - MSN
Nephron Research Adjusts Cencora Price Target to $335 From $325 - marketscreener.com
Cencora, Inc. (COR) Announces Board Changes: New Appointment and Resignation - GuruFocus
Cencora Announces New Board Appointment Amid Recent Resignation - TipRanks
Cencora Appoints Lori J. Ryerkerk To Board - citybiz
Cencora appoints new board member to boost growth By Investing.com - Investing.com India
Cencora Elects Lori J. Ryerkerk to Its Board of Directors | COR Stock News - GuruFocus
Cencora appoints new board member to boost growth - Investing.com
Cencora Elects Lori J. Ryerkerk To Its Board Of Directors - marketscreener.com
Global Supply Chain Expert and Former Fortune 500 CEO Lori Ryerkerk Strengthens Cencora Board - Stock Titan
Baird Adjusts Price Target on Cencora to $351 From $350, Maintains Outperform Rating - marketscreener.com
Beat the Market the Zacks Way: GE Aerospace, Monster Beverage, Cencora in Focus - MSN
Cencora Completes €1 Billion Senior Notes Sale - TipRanks
Insider Sell: Steven Collis Sells Shares of Cencora Inc (COR) - GuruFocus
Cencora, Inc. (COR) Announces €1 Billion Senior Notes Offering - GuruFocus
Cencora Enters €1 Billion Senior Notes Agreement - TipRanks
Robust Results Lifted Cencora (COR) Amid Upgraded Outlook - Insider Monkey
Jim Cramer Highlights Cencora (COR) “Knocked It Out of The Park” - Insider Monkey
8 Stocks on Jim Cramer’s Radar Recently - Insider Monkey
Cencora, Inc. concludes securities offering without stabilisation action By Investing.com - Investing.com Nigeria
Insider Sell Alert: Lon Greenberg Sells 3,000 Shares of Cencora Inc (COR) - GuruFocus
Cencora Director Sells Stock in Major Transaction - TipRanks
Cencora Continues To Deliver As A Healthcare Distributor With Further Growth Signs - Seeking Alpha
Cencora, Inc. concludes securities offering without stabilisation action - Investing.com
Cencora, Inc. announces potential market stabilization measures By Investing.com - Investing.com South Africa
Cencora Reports Strong Q2 2025 Results, Raises Outlook - MSN
Cencora Files For Two-Part Senior Notes Offering Size Not Disclosed- SEC Filing - marketscreener.com
Cencora, Inc. announces potential market stabilization measures - Investing.com
Cencora increases FY2025 EPS guidance to $15.70-$15.95 amid specialty growth - MSN
Cencora's (NYSE:COR) Soft Earnings Don't Show The Whole Picture - Yahoo Finance
Do Wall Street Analysts Like Cencora Stock? - MSN
Transcript : Cencora, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 11 - marketscreener.com
JPMorgan Adjusts Price Target on Cencora to $326 From $301, Maintains Overweight Rating - marketscreener.com
Beat the Market the Zacks Way: Limbach, Stride, Cencora in Focus - Yahoo Finance
Is It Smart To Buy Cencora, Inc. (NYSE:COR) Before It Goes Ex-Dividend? - Yahoo Finance
Cencora, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Yahoo Finance
Cencora Inc Azioni (COR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.15%
0.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):